Frisk Per, Hagberg Hans, Mandahl Agneta, Söderberg Per, Lönnerholm Gudmar
Akademiska barnsjukhuset, Uppsala.
Lakartidningen. 2002 Mar 27;99(13):1444-7.
Bone marrow transplantation (BMT) is an established treatment of hematological malignancies in children. With a rapidly increasing number of long-term survivors, more attention is focused on late sequelae to this therapy. Several cataractogenic factors are involved in BMT, such as ionizing irradiation, corticosteroid treatment, and chemotherapeutic agents. Lens opacity is therefore a potential late side-effect of BMT. The incidence and degree of cataract in 29 children who had undergone autologous or syngeneic BMT were recorded. Median follow-up was eight years (4-10 years). 21 children had received total body irradiation prior to BMT; they all developed cataract of the posterior subcapsular type after three years (median). Six children needed surgical repair in the form of intraocular lens implantation after extracapsular cataract extraction.
骨髓移植(BMT)是治疗儿童血液系统恶性肿瘤的一种成熟疗法。随着长期存活者数量的迅速增加,人们越来越关注这种疗法的晚期后遗症。骨髓移植涉及多种致白内障因素,如电离辐射、皮质类固醇治疗和化疗药物。因此,晶状体混浊是骨髓移植潜在的晚期副作用。记录了29例接受自体或同基因骨髓移植儿童的白内障发病率和程度。中位随访时间为8年(4 - 10年)。21例儿童在骨髓移植前接受了全身照射;三年后(中位时间),他们均出现了后囊下型白内障。6例儿童在囊外白内障摘除术后需要通过植入人工晶状体进行手术修复。